Anatomy/Hormone List
(Redirected from Hormones)
Jump to navigation
Jump to search
Hormones are part of the endocrine system, one of the systems in a rotation as part of the event Anatomy. A complete list of hormones is hard to find, as some are debatable. Nonendocrine glands do have a way of showing up on tests, so they are included.
Hormone name | Secreted by | Produced by | Effect | Structure | Mechanism | Notes (if applicable) |
---|---|---|---|---|---|---|
Activin | Gonads, pituitary gland, placenta | Gonads, pituitary gland, placenta | Enhances FSH biosynthesis and secretion; participates in the regulation of the menstrual cycle; increases FSH binding and FSH-induced aromatization; participates in androgen synthesis enhancing LH action in the ovary and testis (in the male, enhances spermatogenesis); improves wound healing and enhances scar formation; regulates the morphogenesis of branching organs such as the prostate, lung, and especially kidney | Dimers composed of two identical or very similar beta subunits | Activin receptors I and II | Total opposite of inhibin |
Adiponectin (GBP-28, apM1, AdipoQ and Acrp30) | Adipocytes | Adipocytes | Regulates metabolism of lipids, glucose; influences body's response to insulin; has anti-inflammatory effects on the cells lining the walls of blood vessels | Polypeptide | n/a | High quantities are associated with people at a low risk for a heart attack; low levels are associated with obesity |
Adrenocorticotropic hormone/corticotropin (ACTH) | Anterior pituitary | Corticotrope of anterior pituitary | Stimulates secretion of glucocorticoids | Peptide | cAMP | Is a response to corticotropin-releasing hormone; 'stress management’ |
Aldosterone | Adrenal cortex | Adrenal cortex | Increases resorption of sodium, water; releases potassium in kidneys; increases blood pressure | Steroid- mineralocortoid (representative) | Direct | Responds to low salt levels |
Androstenedione | Adrenal glands, gonads | Theca cells in ovaries | Provide androstenedione substrate for estrogen production in granulosa cells | Steroid- sex (androgen) | Direct | Precursor to testosterone, sold as a muscle strengthener; however, along with granulosa cells, makes up estrogen |
Angiotensinogen, angiotensin (AGT) | Liver | Liver | Causes blood vessels to constrict and promotes sodium retention, thereby raising blood pressure; stimulates release of aldosterone | Peptide | IP3 | Angiotensinogen is a precursor to angiotensin |
Antidiuretic hormone/vasopressin (ADH) | Posterior pituitary | Hypothalamus | Controls body's retention of water; prevents production of dilute urine; retains water in kidneys; releases ACTH | Peptide | Varies | Also called arginine vasopressin or argipressin; secreted in response to reductions in plasma volume, increases in the plasma osmolality, and cholecystokinin by the small intestine |
Anti-müllerian hormone (AMH) | Sertoli cells of the testes | Sertoli cells of the testes | Prevents development of müllerian ducts into the uterus and other müllerian structures | Peptide | n/a | Is somewhat detectable in females after 8 years old, but after 25 declines away into barely detectable levels at menopause; is high in males throughout childhood but declines afterward |
Atrial natriuretic peptide (ANP) | Cardiac myocytes of the atria of the heart | Cardiac myocytes of the atria of the heart | Renal: Reduces reabsorption of tubular fluid and increases excretion.; decreases sodium reabsorption; inhibits renin secretion, thereby inhibiting the renin-angiotensin system; reduces aldosterone secretion by the adrenal cortex. Vascular: relaxes vascular smooth muscle. Adipose: increases the release of free fatty acids from adipose tissue | Peptide | cGMP | Is response to: atrial distention; sympathetic stimulation of β-adrenoceptors; hypernatremia; angiotensin-II; endothelin |
Brain natriuretic peptide (BNP) | Cardiac ventricles | Cardiac ventricles | Similar to ANP, but with a lesser effect: decreases systemic vascular resistance and central venous pressure as well as increases natriuresis | Peptide | n/a | The net effect of BNP and ANP is a decrease in blood volume and a decrease in cardiac output |
Calcitonin (CT) | Parafollicular/C cells of the thyroid | Parafollicular/C cells of the thyroid | Inhibits Ca2+ absorption by the intestines; inhibits osteoclast activity; inhibits phosphate reabsorption by the kidney tubules; increases tubular reabsorption of Ca2+, leading to decreased rates of its loss in urine | Peptide | cAMP | Stimulated by an increase in serum [Ca2+]; gastrin and pentagastrin |
Calcitriol | Proximal tubule of the nephron in the kidneys | Proximal tubule of the nephron in the kidneys | Increases blood calcium levels: promotes absorption of dietary calcium from GI tract; increased renal tubular reabsorption of calcium (reduces loss of calcium in urine); also stimulates release of calcium from bone; inhibits release of calcitonin | Sterol | Direct | Active form of vitamin D3 |
Cholecystokinin (CCK) | Mucosal epithelial cells in duodenum; neurons in the enteric nervous system | Mucosal epithelial cells in duodenum; neurons in the enteric nervous system | Releases digestive enzymes from pancreas; contraction of gallbladder to deliver bile | Peptide | n/a | Stimulates digestion of fat and protein; acts as hunger suppressant |
Corticotropin-releasing hormone (CRH) | Hypothalamus | Hypothalamus, T lymphocytes, placenta | Stimulates release of corticotropin from anterior pituitary | Peptide | cAMP | Originally called corticoliberin or corticotropin-releasing factor (CRF) |
Cortisol | Adrenal cortex | Adrenal cortex | Increases blood sugar; suppresses immune system; aids in fat, protein, and carbohydrate metabolism; decreases bone formation; prevents the release of substances in the body that cause inflammation | Steroid- glucocorticoid | Direct | 'Stress hormone'; used to treat osteoporosis, eczema; diuretic hormone |
Dehydroepiandrosterone (DHEA) | Zona reticularis of adrenal cortex, gonads, brain | Zona reticularis of adrenal cortex, gonads, brain | Virilization; anabolic | Steroid- sex (androgen, neurosteroid) | Direct | Prohormone for sex steroids; buffer, reservoir; sometimes used as performance-enhancer, but has been proven to not work |
Dihydrotestosterone (DHT) | Prostate gland, testes, hair follicles, and adrenal glands | Prostate gland, testes, hair follicles, and adrenal glands | Helps form male external genitalia as a fetus; as an adult, acts as the primary androgen in the prostate and hair follicles | Steroid- sex (androgen) | Direct | Prohormone to sex steroids; primary contributing factor in male pattern baldness. Women with increased levels of DHT may develop certain androgynous male secondary sex characteristics, including a deepened voice and facial hair |
Dopamine (DPM/PIH/DA) | Hypothalamus | Hypothalamus | Increases heart rate, blood pressure; inhibits release of prolactin and TRH from anterior pituitary | Amine- tyrosine (catecholamine) | n/a | Also a neurotransmitter |
Endothelin (ET) | Stomach | Vascular endothelium | Constricts blood vessels; raises blood pressure | Amine- protein | cGMP | Formation and release are stimulated by angiotensin II, antidiuretic hormone, thrombin, cytokines, reactive oxygen species, and shearing forces acting on the vascular endothelium; releace is inhibited by prostacyclin and atrial natriuretic peptide as well as by nitric oxide |
Enkephalin | Posterior horn of gray matter of the spinal cord | Posterior horn of gray matter of the spinal cord | Regulates nociception in the body | Peptide (opinoid) (endorphins) | n/a | Have potent opiate-like effects, probably serve as neurotransmitters |
Epinephrine/adrenaline (EPI) | Adrenal medulla | Adrenal medulla | Boosts supply of oxygen and glucose to the brain and muscles, while suppressing other non-emergency bodily processes (digestion in particular); increases heart, respiratory rate; vasoconstriction or vasodilation; stimulates glycogenolysis; triggers lipolysis | Amine- tyrosine (catecholamine) | n/a | Is part of “fight or flight” response; also a neurotransmitter |
Erythropoietin (EPO) | Peritubular capillary endothelial cells in the kidney and liver | Peritubular capillary endothelial cells in the kidney and liver | Promotes differentiation, development of red blood cells; initiates production of hemoglobin; regulates red blood cell production; plays an important role in the brain's response to neuronal injury; is involved in the wound healing process | Peptide | n/a | Is triggered by low oxygen levels; is prime regulator of blood cell production; cytokine for erythrocyte precursors in the bone marrow |
Estradiol (E2) | Ovary and testis | Granulosa cells of the ovaries; also produced by the adrenal cortex, and (in men), by the testes; the brain and in arterial walls | Females: Promotes formation of female secondary sex characteristics; accelerates height growth, metabolism; reduces muscle mass; stimulates endometrial growth; increases uterine growth; increases bone formation; reduces bowel motility; increases cholesterol in bile. Males: Prevents apoptosis of germ cells | Steroid- sex (estrogen) | Direct | Is primary estrogen |
Estriol/oestriol | Placenta | Placenta | Has weak effects similar to estradiol’s | Steroid- sex (estrogen) | Direct | Is one of three principal estrogens; in pregnant women with MS, estriol reduces the disease's symptoms noticeably; can be a weak or strong estrogen depending on if it is given acutely or chronically when given to immature animals, but is an antagonist when given with estradiol; almost always present in reproductive female body |
Estrone/oestrone | Ovary, adipose | Ovary, adipose | Has effects similar to estradiol's | Steroid- sex (estrogen) | Direct | Is one of three principal estrogens; predominant estrogen in postmenopausal women yet the least common estrogen |
Follicle-stimulating hormone (FSH) | Gonadotrophs of the anterior pituitary | Gonadotrophs of the anterior pituitary | Both: regulates the development, growth, pubertal maturation, and reproductive processes of the human body; stimulates the maturation of germ cells. Males: induces sertoli cells to secrete inhibin; stimulates the formation of sertoli-sertoli tight junctions (zonula occludens); stimulates maturation of seminiferous tubules and spermatogenesis; enhances the production of androgen-binding protein by the Sertoli cells of the testes by binding to FSH receptors on their basolateral membranes; is critical for the initiation of spermatogenesis. Females: initiates follicular growth, specifically affecting granulosa cells. Levels fluctuate with menstrual cycle, peaking at day 3 | Peptide | cAMP | At the end of the luteal phase, there is a slight rise in FSH that seems to be of importance to start the next ovulatory cycle; partners with LH; release controlled by pulses of GnRH |
Gastrin | G cells in the stomach, duodenum, and the pancreas | G cells in the stomach, duodenum, and the pancreas | Stimulates parietal cells of the stomach to HCl; stimulates parietal cell maturation and fundal growth; causes chief cells to secrete pepsinogen, inactive form of the digestive enzyme pepsin; increases antral muscle mobility and promotes stomach contractions; strengthens antral contractions against the pylorus, and constricts the pyloric sphincter, slowing gastric emptying; plays a role in the relaxation of the ileocecal valve; induces pancreatic secretions and gallbladder emptying; relaxes lower esophageal sphincter (LES) tone | Peptide | n/a | Gene located on the long arm of the 17th chromosome; found primarily in three forms: gastrin-34 ("big gastrin"), gastrin-17 ("little gastrin"), gastrin-14 ("minigastrin"); pentagastrin is an artificially synthesized, five amino acid sequence identical to the last five amino acid sequence at the C-terminus end of gastrin – the numbers refer to the amino acid count. Released in response to certain stimuli: stomach distension; vagal stimulation (mediated by the neurocrine bombesin, or GRP in humans); the presence of partially digested proteins; hypercalcemia. Release inhibited by: the presence of acid in the stomach; somatostatin; gastrin; secretin; GIP (gastroinhibitory peptide); VIP; glucagon; calcitonin |
Ghrelin | P/D1 cells lining the fundus of the human stomach and epsilon cells of the pancreas; the hypothalamic arcuate nucleus | P/D1 cells lining the fundus of the human stomach and epsilon cells of the pancreas; the hypothalamic arcuate nucleus | Promotes intestinal cell proliferation; inhibits GI apoptosis during inflammatory states and oxidative stress; suppresses the pro-inflammatory mechanisms of GI; augments GI anti-inflammatory mechanisms; enhances the motility of gastrointestinal tract, as does motilin; promotes gastrointestinal and pancreatic malignancy. In fetuses, it seems that it is produced early by the lung and promotes growth | Peptide | n/a | Is counterpart of leptin; exists as an endocrinological inactive (pure peptide) and an active (octanoylated) form |
Glucagon (GCG) | α-cells of the islets of Langerhans in the pancreas | α-cells of the islets of Langerhans in the pancreas | Maintains level of glucose in the blood; turns off glycolysis in the liver; regulates the rate of glucose production through lipolysis; stimulates insulin production | Peptide | cAMP | Discovered by Kimball and Murlin; has structure of NH2-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser- Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-COOH |
Gonadotropin-releasing hormone (GnRH) | Preoptic area of the hypothalamus | Preoptic area of the hypothalamus, hypophysial portal bloodstream at the median eminence | Stimulates the synthesis and secretion of FSH and LH; controls follicular growth, ovulation, and corpus luteum maintenance in the female; spermatogenesis in the male | Peptide | IP3 | Neurohormone; in males, secreted in pulses at a constant frequency; but in females, the frequency of the pulses varies during the menstrual cycle, and there is a large surge of GnRH just before ovulation; pulsatile for all vertebrates; very low during childhood – activated at puberty; stimulated by LH, kisspeptin; found in cancers of the breast, ovary, prostate, and endometrium |
Growth hormone (GH/HGH) | Somatotroph cells within lateral wings of anterior pituitary | Somatotroph cells within lateral wings of anterior pituitary | Effects can generally be described as anabolic. Increased height during childhood and adolescence; increases calcium retention; strengthens and increases mineralization of bone; increases muscle mass via sarcomere hyperplasia; promotes lipolysis; increases protein synthesis; stimulates the growth of all internal organs excluding the brain; plays a role in homeostasis; reduces liver uptake of glucose; promotes gluconeogenesis in liver; contributes to the maintenance and function of pancreatic islets; stimulates the immune system | Protein-based peptide | Stimulates growth via MAPK/ERK, JAK/STAT | Natural growth hormone. Secretion include peptide hormones; GHRH through binding to the growth hormone-releasing hormone receptor (GHRHR); ghrelin through binding to growth hormone secretagogue receptors (GHSR); sex hormones; increased androgen secretion during puberty (males from testis and females from adrenal cortex); estrogen; clonidine and L-DOPA by stimulating GHRH release; hypoglycemia, arginine, propranolol by inhibiting somatostatin release; deep sleep; fasting; vigorous exercise. Inhibitors of GH secretion include somatostatin from the periventricular nucleus; circulating concentrations of GH and IGF-1 (negative feedback on the pituitary and hypothalamus); hyperglycemia; glucocorticoids; dihydrotestosterone. |
Growth hormone-releasing hormone (GHRH)/somatocrinin | Arcuate nucleus of the hypothalamus | Arcuate nucleus of the hypothalamus | Stimulates GH production and release by binding to the GHRH receptor on cells in the anterior pituitary | Amino acid peptide | cAMP, IP3 | Neurohormone; Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 |
Histamine | Granules in mast cells (especially numerous at sites of potential injury) or in basophils | Granules in mast cells (especially numerous at sites of potential injury) or in basophils; non-mast cell histamine is found in several tissues, including the brain, where it is a neurotransmitter; enterochromaffin-like (ECL) cell of the stomach | Bronchoconstriction, bronchial smooth muscle contraction, separation of endothelial cells (responsible for hives), and pain and itching due to insect stings; the primary receptors involved in allergic rhinitis symptoms and motion sickness; sleep regulation; vasodilation; stimulates gastric acid secretion; decreased neurotransmitter release: histamine, acetylcholine, norepinephrine, serotonin; plays a role in chemotaxis | Amine- histidine | H1histamine receptor (muscle, endothelium, CNS tissue); H2histamine receptor (parietal, vascular smooth muscle cells); H3histamine receptor (CNS and to a lesser extent PNS tissue); H4histamine receptor (basophils, bone marrow, thymus, intestine, spleen, colon) | Formula: C5H9N3. “H substance”/”substance H” |
Human chorionic gonadotropin (hCG) | Developing embryo after conception and later by syncytiotrophoblast (part of placenta) | Produced in pregnancy; made by the developing embryo after conception and later by syncytiotrophoblast (part of placenta) | Interacts with LHCG receptor; promotes maintenance of corpus luteum during beginning of pregnancy, causing it to secrete progesterone; may repel immune cells of the mother, protecting fetus during 1st trimester; may be a placental link for development of local maternal immunotolerance; plays a role in cellular differentiation/proliferation and may activate apoptosis | Glycoprotein | cAMP | Used as a tumor marker, for fertility, weight loss, and as an anabolic steroid |
Human placental lactogen (HPL)/human chorionic somatomammotropin | Placenta | n/a | Affects the metabolic system of the maternal organism; decreases maternal insulin sensitivity, raising maternal blood glucose levels while decreasing maternal glucose utilization, ensuring adequate fetal nutrition; increases production of insulin; increases insulin resistance and carbohydrate intolerance; facilitates energy supply of fetus | Polypeptide | n/a | Is similar to HGH; in a bioassay, mimics the action of prolactin (it is unclear whether it has any role in lactation); chronic hypoglycemia leads to its level rising |
Inhibin | Gonads (granulosa cells of the ovarian follicles; Sertoli cells of testes), pituitary gland, placenta | Gonads (granulosa cells of the ovarian follicles; Sertoli cells of testes), pituitary gland, placenta | Suppresses FSH synthesis; inhibits FSH secretion/production and GnRH release from the hypothalamus | Dimers composed of two similar beta subunits | Unknown | Inhibin B reaches a peak in the early- to mid-follicular phase, and a second peak at ovulation; inhibin A reaches its peak in the mid-luteal phase. Secretion is diminished by GnRH, enhanced by insulin-like growth factor-1 (IGF-1); production stimulated by androgens |
Insulin | Pancreas within the β-cells of the islets of Langerhans | Pancreas within the β-cells of the islets of Langerhans | Controls cellular intake of certain substances (mostly glucose in muscle and adipose tissue); increases DNA replication and protein synthesis via control of amino acid uptake; modifies the activity of numerous enzymes; forces storage of glucose in liver (and muscle) cells in the form of glycogen; forces fat cells to take in blood lipids, which are converted to triglycerides; forces adipose tissue to make fats (i.e., triglycerides) from fatty acid esters; decreases breakdown of protein; reduction in conversion of fat cell lipid stores into blood fatty acids; decreases production of glucose from non-sugar substrates, primarily in the liver; decreases level of degradation of damaged organelles; forces cells to absorb circulating amino acids; forces cells to absorb serum potassium; forces arterial wall muscle to relax, increasing blood flow, especially in micro arteries; increases secretion of hydrochloric acid by parietal cells in the stomach | Peptide | Tyrosine kinase | Low levels cause diabetes mellitus |
Insulin-like growth factor (IGF) | Hepatocytes of liver | Hepatocytes of liver | Acts as a neurotrophic factor, inducing the survival of neurons; causes skeletal muscle hypertrophy by inducing protein synthesis and blocking muscle atrophy; protective for cartilage cells; associated with activation of osteocytes, and thus may be an anabolic factor for bone; at high concentrations, capable of activating the insulin receptor, it can also complement for the effects of insulin; regulates neural development including neurogenesis, myelination, synaptogenesis, and dendritic branching and neuroprotection after neuronal damage; shapes the development of the cochlea; controls apoptosis | Polypeptide | Tyrosine kinase | Stimulated by growth hormone; very similar to insulin |
Leptin (LEP) | White adipose tissue (mostly); brown adipose tissue; placenta (syncytiotrophoblasts); ovaries; skeletal muscle; stomach (lower part of fundic glands); mammary epithelial cells; bone marrow; pituitary; liver; gastric chief, P/D1 cells in stomach | Inhibits appetite (counteracts effects of NPY, anandamide (potent feeding stimulant) (inhibition is long-term); promotes the synthesis of α-MSH (appetite suppressant) | Peptide | n/a | Is response to fatty foods; absence leads to uncontrolled food intake and subsequent obesity; levels directly proportional to total amount of fat in body; from Greek leptos (thin) | |
Leukotrienes | Leukocytes (mast cells, eosinophils, neutrophils, monocytes, cells, eosinophils, neutrophils, monocytes, basophils) | Leukocytes (mast cells, eosinophila, neutrophils, monocytes, basophils) | Are involved in asthmatic and allergic reactions; act to sustain inflammatory reactions; have a chemotactic effect on migrating neutrophils; have a powerful effect in bronchoconstriction and increase vascular permeability | Eicosanoid | Synthesized from arachindonic acid by 5-lipoxygenase | Contributes to inflammation in asthma and bronchitis |
Lipotropin | Anterior pituitary | Anterior pituitary | Stimulates melanocytes to produce melanin; lipolysis; steroidogenesis | Polypeptide | Produced by the cleavage of pro-opiomelanocortin (POMC) (AP produces the POMC, which undergoes cleavage to ACTH and β-lipotropin) | γ-lipotropin (56 amino acids), α-MSH, β-MSH, γ-MSH, α-endorphin, β-endorphin, γ-endorphin, and met-enkephalin are all possible fragments of β-lipotropin |
Luteinizing hormone (LH) | n/a | n/a | Female: Ovulation. Males: Stimulates Leydig cell production of testosterone | Peptide | cAMP | n/a |
Melanocyte-stimulating hormone (MSH) | Intermediate pituitary | Intermediate pituitary | Stimulates production and release of melanin by melanocytes in skin and hair; will cause a darkening in humans too | Peptide | cAMP | Increases in humans during pregnancy; in people who cannot tan/have red hair, the variance is in the hormone receptor, making them unresponsive to MSH |
Melatonin | Pineal | Liver (mostly), urine, saliva | Forms part of the system that regulates the sleep-wake cycle by chemically causing drowsiness and lowering the body temperature; promotes sleepiness; exerts a powerful antioxidant activity; prevent the damage to DNA by some carcinogens; interacts with the immune system (how remains unclear) | Amine- tryptophan | n/a | Infants' levels become regular in about the third month after birth, with the highest levels measured between midnight and 8 AM; production decreases as a person ages; production inhibited by light and permitted by darkness (“hormone of darkness”); onset each evening called the Dim-Light Melatonin Onset (DLMO); secretion, levels of of melatonin peak in the middle of the night, and gradually falls during the second half of the night; blue light around 460 to 480 nm, suppresses melatonin; levels high in those with vivid dreaming and hallucinations; autistic individuals may have lower than normal levels of melatonin; C13H16N2O2 |
Neuropeptide Y (NPY) | Hypothalamus | Hypothalamus | Regulates energy balance, memory and learning, epilepsy; increases food intake; decreases physical activity; increases proportion of energy stored as fat; blocks nociceptive signals to brain; augments vasoconstrictor effects of noradrenergic neurons | Peptide neurotransmitter | NPY receptors | Associated with obesity, anorexia nervosa |
Norepinephrine/noradrenaline (NE/NA) | Adrenal medulla | Adrenal medulla and postganglionic neurons of sympathetic nervous system | Increases heart rate; triggers release of glucose from energy stores; increases blood flow to skeletal muscle; increases the brain's oxygen supply; suppresses neuroinflammation when released in the brain from the locus ceruleus | Amine- tyrosine (catecholamine) | Adrenergic receptors | Part of fight-or-flight response; neurotransmitter; stress hormone; synthesized from dopamine |
Orexin/hypocretins | Lateral and posterior hypothalamus | Lateral and posterior hypothalamus | Promotes wakefulness, increases body temperature, locomotion and elicits a strong increase in energy expenditure; increases the craving for food, and correlates with the function of the substances that promote its production; very important link between metabolism and sleep regulation | Neuropeptide | n/a | Linked to Alzheimer’s |
Oxytocin | Posterior pituitary | Magnocellular neurosecretory cells of the supraoptic and paraventricular nuclei of hypothalamus | Letdown reflex; uterine contraction during labor; sexual arousal; feelings of contentment, reductions in anxiety, and feelings of calmness and security around mate; human bonding and decrease in fear; can reduce excretion of urine slightly; indirectly inhibits release of adrenocorticotropic hormone and cortisol; reduces trust of strangers; increases cultural and racial bias; emotional bonding; maternal behavior; prepares fetal neurons for delivery to placenta | Peptide (cys-tyr-ile-gln-asn-cys-pro-leu-gly) | n/a | Triggered by cervical/uterine stretching, suckling of infant |
Parathyroid hormone (PTH) | Parathyroid | Parathyroid | Enhances release of calcium from bones; enhances active reabsorption of calcium and magnesium from distal tubules into kidney; increases the excretion of phosphate, with a net loss in plasma phosphate concentration; enhances the absorption of calcium in the intestine by increasing the production of activated vitamin D; increases breakdown of bone by osteoclasts | Peptide | cAMP | Controlled by negative feedback; opposite of calcitonin |
Progesterone (P4) | Ovary, adrenal glands, placenta | Ovary, adrenal glands, placenta | Converts endometrium to its secretory stage to prepare the uterus for implantation; affects the vaginal epithelium and cervical mucus, making it thick and impenetrable to sperm; decreases maternal immune response to allow for the acceptance of the pregnancy; contractility of the uterine smooth muscle; inhibits lactation during pregnancy; raises epidermal growth factor-1 levels, a factor often used to induce and sustain stem cells; increases core temperature during ovulation; reduces spasm; relaxes smooth muscle; widens bronchi; regulates mucus; acts as an anti-inflammatory agent; regulates immune response; reduces gall-bladder activity; normalizes blood clotting and vascular tone, zinc and copper levels, cell oxygen levels, and use of fat stores for energy; may affect gum health, increasing risk of gingivitis and tooth decay; regulates effects of estrogen | Steroid- sex (progestagen) | Direct | Pregnancy hormone |
Prolactin (PRL)/luteotropic hormone (LTH) | Hypothalamus, anterior pituitary | Lactotropes | Regulates lactation; stimulates proliferation of oligodendrocyte precursor cells; stimulates the mammary glands for lactation; sexual gratification (counteracts effect of dopamine, which is responsible for sexual arousal); stimulates proliferation of oligodendrocyte precursor cells; contributes to surfactant synthesis of the fetal lungs at the end of the pregnancy and immune tolerance of the fetus by the mo during pregnancy; decreases normal levels of sex hormones (estrogen in women and testosterone in men); enhances LH-receptors in Leydig cells, resulting in testosterone secretion, which leads to spermatogenesis; delays hair regrowth in mice; promotes neurogenesis | Single-chain polypeptide | Prolactin receptor | Inhibited by dopamine; supported by TRH, GRH |
Prostacyclin (PGI2) | Endothelial cells | Endothelial cells | Prevents formation of the platelet plug involved in primary hemostasis; inhibits platelet activation; is an effective vasodilator | Eicosanoid | cAMP | “Epoprostenol” as a drug |
Relaxin (RLN) | Female: corpus luteum of ovary; breast; placenta; chorion; decidua. Male: prostate | Female: corpus luteum of ovary; breast; placenta; chorion; decidua. Male: prostate; semen | Enhances motility of sperm in males | Peptide | Receptors | Belongs in the insulin superfamily |
Renin/angiotensinogenase | Kidney cells (of the afferent arterioles) | Granular cells of the juxtaglomerular apparatus of the kidney | Mediates extracellular volume (blood plasma, lymph and interstitial fluid), arterial vasoconstriction; regulates the body's mean arterial blood pressure | Peptide (406 amino acids) | Circulates in bloodstream and breaks down | Stimulated by a decrease in arterial blood pressure; a decrease in sodium chloride levels in the ultra-filtrate of the nephron; and sympathetic nervous system activity |
Secretin (SCT) | Duodenum | Cytoplasmic secretory granules of S-cells (mainly in mucosa of duodenum, and less so in jejunum of small intestine) | Increases watery bicarbonate solution from pancreatic duct epithelium; increases water and bicarbonate secretion from duodenal Brunner's glands; enhances effects of cholecystokinin to induce secretion of digestive enzymes and bile from pancreas and gallbladder, respectively; counteracts blood glucose concentration spikes by triggering increased insulin release from pancreas, following oral glucoseintake; inhibits gastrin release from stomach; reduces acid secretion from stomach; stimulates pepsin secretion from chief cells, which can help break down proteins in food digestion; stimulates release of glucagon, pancreatic polypeptide and somatostatin | Peptide | n/a | Discovered by William Bayless in 1902, who coined the term ‘hormone’ in 1905 |
Serotonin/ 5-Hydroxytryptamine (5-HT) | Enterochromaffin cells in the gut | Enterochromaffin cells in the gut; serotonergic neurons in the CNS | Regulates mood, appetite, sleep, muscle contractions, memory, and learning; mediates gut movements, perception of resource availability; functions as a neurotransmitter; activates muscles used for feeding; suppresses insulin release from the beta cells in the pancreas; acts as a growth factor; stimulates cellular growth to repair liver damage; activates osteoblasts and osteoclasts | Amine-tryptophan | Serotonylation | Neurotransmitter; found in all bilateral animals; levels affected by diet; released in response to food in lumen |
Somatostatin (SRIF) | Stomach; intestine; delta cells of the pancreas | Neuroendocrine neurons of the periventricular nucleus of the hypothalamus; arcuate nucleus; hippocampus; brainstem nucleus of solitary tract | Inhibits release of GH; inhibits release of TSH; inhibits adenylyl cyclase in parietal cells; suppresses release of gastrointestinal hormones (gastrin; CCK; SCT; motilin; vasoactive intestinal peptide (VIP); gastric inhibitory polypeptide (GIP); enteroglucagon); decreases rate of gastric emptying; reduces smooth muscle contractions and blood flow within intestine; suppresses release of pancreatic hormones; inhibits insulin release when released from delta cells of pancreas; inhibits release of glucagon; suppresses exocrine secretory action of pancreas | Inhibitory peptide | n/a | n/a |
Testosterone | Testes of males and ovaries of females; small amounts by adrenal glands | Testes of males and ovaries of females; small amounts by adrenal glands | Promotes protein synthesis and growth of those tissues with androgen receptors; builds up bone and muscle mass; stimulates linear growth and bone maturation; matures sex organs (particularly penis and scrotum in fetus, and at puberty a deepening of voice, growth of beard and axillary hair); genital virilization; develops prostate and seminal vesicles; adult-type body odor; increased oiliness of skin, hair; acne; appearance of pubic hair; axillary hair; growth spurt; accelerated bone maturation; hair on upper lip and sideburns; enlargement of sebaceous glands; phallic enlargement; increased libido and frequency of erection; pubic hair growth; facial hair; balding; chest, leg, axillary hair; subcutaneous fat in face decreases; increased muscle strength and mass; deepens of voice; growth of Adam's apple; growth of spermatogenic tissue in testicles, male fertility; growth of jaw, brow, chin, nose, and remodeling of facial bone contours; shoulders become broader and rib cage expands; completes bone maturation and termination of growth | Steroid- sex (androgen) | Direct | “Manly” hormone |
Thrombopoietin (TPO) | Liver: parenchymal, sinusoidal endothelial cells; kidney: proximal convoluted tubule cells; striated muscle; stromal cells in bone marrow | Liver: parenchymal, sinusoidal endothelial cells; kidney: proximal convoluted tubule cells; striated muscle; stromal cells in bone marrow | Regulates the differentiation of megakaryocytes, platelets; produces platelets | Peptide | n/a | n/a |
Thromboxane (TXA2) | Platelets | Platelets | A vasoconstrictor, potent hypertensive agent; facilitates platelet aggregation | Eicosanoid | Receptors | n/a |
Thyroid-stimulating hormone (TSH) | Thyrotrope cells in the anterior pituitary | Thyrotrope cells in the anterior pituitary | Stimulates the thyroid gland to secrete T4 and T3 | Peptide | cAMP | n/a |
Thyrotropin-releasing hormone (TRH) | Hypothalamus in medial neurons of the paraventricular nucleus | Hypothalamus in medial neurons of the paraventricular nucleus | Stimulates the release of TSH | Peptide | IP3 | n/a |
Thyroxine (T4)/ triiodothyronine (T3) | Follicular cells of thyroid | Follicular cells of thyroid | Increases basal metabolic rate; stimulates production of RNA Polymerase I and II; increases rate of protein synthesis; increases rate of protein degradation; potentiates effects of β-adrenergic receptors on metabolism of glucose; increases rate of glycogen breakdown and glucose synthesis in gluconeogenesis; potentiates effects of insulin; stimulates breakdown of cholesterol; increases number of LDL receptors; increasing rate of lipolysis; increases heart rate and force of contraction; increases cardiac output; increases systolic blood pressure; decreases diastolic blood pressure; affects lungs; influences postnatal growth of central nervous system; stimulates production of myelin, neurotransmitters, axon growth; important in linear growth of bones | Amine- tyrosine | Direct | n/a |